Domain 1. Scope and Purpose | |
 Item 1. The overall objective(s) of the guideline is (are) specifically described. | |
 Item 2. The health question(s) covered by the guideline is (are) specifically described. | |
 Item 3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described. | |
Domain 2. Stakeholder Involvement | |
 Item 4. The guideline development group includes individuals from all relevant professional groups. | |
 Item 5. The views and preferences of the target population (patients, public, etc.) have been sought. | |
 Item 6. The target users of the guideline are clearly defined. | |
Domain 3. Rigour of Development | |
 Item 7. Systematic methods were used to search for evidence. | |
 Item 8. The criteria for selecting the evidence are clearly described. | |
 Item 9. The strengths and limitations of the body of evidence are clearly described. | |
 Item 10. The methods for formulating the recommendations are clearly described. | |
 Item 11. The health benefits, side effects, and risks have been considered in formulating the recommendations. | |
 Item 12. There is an explicit link between the recommendations and the supporting evidence. | |
 Item 13. The guideline has been externally reviewed by experts prior to its publication. | |
 Item 14. A procedure for updating the guideline is provided. | |
Domain 4. Clarity of Presentation | |
 Item 15. The recommendations are specific and unambiguous. | |
 Item 16. The different options for management of the condition or health issue are clearly presented. | |
 Item 17. Key recommendations are easily identifiable. | |
Domain 5. Applicability | |
 Item 18. The guideline describes facilitators and barriers to its application. | |
 Item 19. The guideline provides advice and/or tools on how the recommendations can be put into practice. | |
 Item 20. The potential resource implications of applying the recommendations have been considered. | |
 Item 21. The guideline presents monitoring and/or auditing criteria. | |
Domain 6. Editorial Independence | |
 Item 22. The views of the funding body have not influenced the content of the guideline. | |
 Item 23. Competing interests of guideline development group members have been recorded and addressed. | |
Overall Guideline Assessment | |
 1. Rate the overall quality of this guideline. | |
 2. I would recommend this guideline for use. |